Registro:

Referencias:

• Dahlback, B., Blood coagulation (2000) Lancet, 355, pp. 1627-1632
• Tollefsen, D., Majerus, D.W., Blank, M.K., Heparin Cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma (1982) J Biol Hem, 257, pp. 2162-2169
• Tollefsen, D., Insight into the mechanism of action of heparin cofactor II (1995) Thromb Hem, 74 (5), pp. 1209-1214
• Bedayan, P., Boccalon, H., Dupouy, D., Boneu, B., Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins (1994) Thromb and Haem, 71 (5), pp. 576-580
• Tollefsen, D.M., Pestka, C.A., Monafo, W., Activation heparin cofactor II by dermatan sulfate (1983) J Biol Chem, 258 (11), pp. 6713-6716
• Rosenberg, R.D., Armand, G., Lam, L., Structure-function relationships of heparin species (1978) Proc Natl Acad Sci, 75 (7), pp. 3065-3069. , USA
• Lindahl, U., Backstrom, G., Hook, M., Thunberg, L., Fransson, L.A., Linker, A., Structure of antithrombin-binding site in heparin (1979) Proc Natl Acad Sci, 76 (7), pp. 3198-3202. , USA
• Maimone, M., Tollefsen, D.M., Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity (1990) J Biol Chem, 265 (39), pp. 18263-18271
• Tollefsen, D.M., Peacock, M.E., Monafo, W.J., Molecular size of Dermatan Sulfate oligosaccharides required to bind an activate Heparin Cofactor II (1986) J Biol Chem, (261), pp. 8854-8858
• Fernández De Recondo, M.E., Legorburu, C., Monge, J.C., Recondo, E.F., Heparin and Concanavalin A interaction. Isolation of fraction with higher anticoagulant activity (1988) Biochem Biophys Res Commun, 155 (1), pp. 216-223
• Monge, J.C., Recondo, E.F., Fernández De Recondo, M.E., Heparin and Concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity (1989) Thromb Res, 54, pp. 237-243
• Monge, J.C., Legorburu, C., Fernández De Recondo, M.E., Recondo, E.F., Heparin and Concanavalin A interaction: A useful model for studying the mechanism of anticoagulant activity (1989) Ann New York Acad Sc, 556, pp. 462-464
• Fernández De Recondo, M.E., Monge, J.C., Recondo, E.F., Interaction of Concanavalin A with a fraction of dermatan sulfate containing a very high anticoagulant activity (1995) Cell Mol Biol, 41 (4), pp. 465-472
• Cruse, J.M., Lewis Jr., R.E., Complement Today. Complement Profiles. Basel, Karger, 1993. Heparin Is Not Just An Anticoagulant Anymore: Six and One-Half Decades of Studies on the Ability of Heparin to Regulate Complement Activity, 1, pp. 96-120. , R. Erik Edens, Robert J. Linhardt, John M. Weiler
• Calabrese, G.C., Recondo, M.M., Fernández De Recondo, M.E., Recondo, E.F., The first component of the human complement system recognizes the active fraction of heparin (1997) Cell and Mol Biol, 43 (2), pp. 237-242
• Calabrese, G.C., Leocata Nieto, F., Recondo, E.F., Fernández De Recondo, M.E., An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system (2001) Cell and Mol Biol, 47 (17), pp. 127-131
• Calabrese, G.C., Recondo, E.F., Fernández De Recondo, M.E., Antithrombin and first protein C1 recognize the same active heparin fraction (2002) Thromb Res, 105, pp. 537-541
• Almeda, S., Rosenberg, R.D., Bing, D.H., The binding properties of human complement component C1q; interaction with mucopolysaccharides (1983) J Biol Chem, 258, pp. 785-791
• Calabrese, G.C., Alberto, M.F., Tubio, R., Marani, M., Fernández De Recondo, M.E., Lazzari, M., A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein (2004) Thromb Res, 113, pp. 243-250
• Imbimbo, B.P., Sié, P., Agnelli, G., Saivin, S., Dupouy, D., Damiani, M., Intramuscular dermatan sulfate MF701 in patients with hip fracture: Relationship between pharmacokinetics and antithrombotic efficacy (1994) Thromb Haem, 71 (5), pp. 553-557
• Pavao, M., Aiello, K.R., Werneck, C., Silva, L., Valente, A.P., Mulloy, B., Highly sulfated dermatan sulfate from ascidians. Structure versus anticoagulant activity of these glycosaminoglycans (1998) J Biol Chem, 273 (43), pp. 27848-27857
• Mascellani, G., Liverani, L., Parma, B., Bergonzini, G., Bianchini, P., Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II (1996) Throm Res, 84 (1), pp. 21-32
• Bing, D., Purification of the first component of human complement by affinity chromatography on human gamma globulin linked to sepharose (1971) J Immunol, 107 (5), pp. 1243-1249
• Twlikki, T., Terho, T., Hartiala, K., Method for determination of the sulfate content of glycosaminoglycans (1971) Anal Biochem, 41, pp. 471-476
• Doutremepuich, C., Azougagh Oualane, F., Doutremepuich, F., Fareed, J., New class of heparin derivates with a potent antithrombotic effect and a very limited hemorrhagic activity (1996) Thromb Res, 83 (3), pp. 217-228
• Fareed, J., Hoppensteadt, D., Bick, R., An update on heparins at the beginning of the new millennium (2000) Sem Thromb Haem, 26 (1), pp. 5-21
• Bedayan, P., Boccalon, H., Dupouy, D., Boneu, B., Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins (1994) Thromb Haem, 71 (5), pp. 576-580
• Griffith, M.J., Marbet, G.A., Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II (1983) Biochem Biophys Res Commun, (112), pp. 663-670

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------